Abstract

High intraindividual performance variability is one of the most robust findings to emerge in cognitive-experimental research of attention deficit hyperactivity disorder (ADHD). Evidences from studies incorporating structural or functional human brain mapping methods indicate that this increased intraindividual variability is not simply a sequel of general brain dysfunction, but is likely related to the functioning of neural circuits that engage the prefrontal cortex, particularly the dorsolateral areas (dlPFC). In order to examine further the anatomical and pharmacological substrate responsible for this high intraindividual variability disorder, we injected GABAA antagonist (bicuculline) or GABAA agonist (muscimol) in the dlPFC of monkeys performing a reflexive oculomotor task. Here we show that, whereas GABAA agonist injection induced no or minimal impairments, injection of GABAA antagonist dramatically increased the intraindividual variability of saccade response time and of saccade spatial accuracy (amplitude and direction). Overall, this study demonstrates that the balance between excitatory/inhibitory activities in the dlPFC is fragile but crucial, since local micro-injection of GABAA antagonist can induce marked behavioural effects. It also reveals that higher cognitive areas such as the dlPFC are markedly capable to influence the productions and metrics of reflexive movements. Altogether, this study provides promising perspectives for the development of new therapeutic strategies for the treatment of diseases in which high intravariability disorders are a prominent feature.

Highlights

  • Significant and reliable differences in the speed and the variability of responses have been documented between attention deficit hyperactivity disorder (ADHD) and typically developing children (TDC) across a wide variety of neuropsychological tasks [1,2]

  • Evidences from studies incorporating structural or functional human brain mapping methods indicate that this intraindividual variability may not be a sequel of general brain dysfunction, but may likely be related to the functioning of neural circuits that, among other brain areas, engage the prefrontal cortex, the dorsolateral areas [5,6,7,8,9,10,11,12,13,14]

  • Across monkeys and injection sites, the serial correlations obtained after GABAA antagonist injections is lower than GABAA agonist injections at lags up to 6 trials (U(15,11) = 336, p = .03 )

Read more

Summary

Introduction

Significant and reliable differences in the speed and the variability of responses have been documented between ADHD and typically developing children (TDC) across a wide variety of neuropsychological tasks [1,2]. Response variability correlates more strongly and reliably with ratings of ADHD symptoms than commission errors or other outcome measures [4]. In order to examine further the anatomical and pharmacological substrate of this high intraindividual variability disorder, we injected a GABAA antagonist (bicuculline) or a GABAA agonist (muscimol) in the dlPFC of monkeys performing a reflexive oculomotor task (see supplementary information). We show that specific and focal perturbation of GABA-mediated circuit in the dlPFC is capable to generate high intraindividual performance variability

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call